Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| enGene Holdings Inc. | 238,851 | reported | 20 Feb 2024 | tx 2+800,000 |
| Edesa Biotech, Inc. | 175,454 | reported | 02 Nov 2020 | tx 12+2,147,060−70,314 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 20 Feb 2024 | GRANT_AWARD | enGene Holdings Inc. | 155,035 | 10.00 USD | |
| 20 Feb 2024 | GRANT_AWARD | enGene Holdings Inc. | 644,965 | 10.00 USD | |
| 02 Nov 2020 | EXERCISE | Edesa Biotech, Inc. | 5,952 | 4.00 USD | |
| 02 Nov 2020 | EXERCISE | Edesa Biotech, Inc. | 64,362 | 4.00 USD | |
| 02 Nov 2020 | EXERCISE | Edesa Biotech, Inc. | 5,952 | 0.00 USD | deriv |
| 02 Nov 2020 | EXERCISE | Edesa Biotech, Inc. | 64,362 | 0.00 USD | deriv |
| 08 Jan 2020 | PURCHASE | Edesa Biotech, Inc. | 128,722 | 3.20 USD | |
| 08 Jan 2020 | PURCHASE | Edesa Biotech, Inc. | 11,903 | 3.20 USD | |
| 08 Jan 2020 | PURCHASE | Edesa Biotech, Inc. | 64,362 | — | deriv |
| 08 Jan 2020 | PURCHASE | Edesa Biotech, Inc. | 8,928 | — | deriv |
| 08 Jan 2020 | PURCHASE | Edesa Biotech, Inc. | 5,952 | — | deriv |
| 08 Jan 2020 | PURCHASE | Edesa Biotech, Inc. | 96,542 | — | deriv |
| 07 Jun 2019 | GRANT_AWARD | Edesa Biotech, Inc. | 148,999 | 0.00 USD | |
| 07 Jun 2019 | GRANT_AWARD | Edesa Biotech, Inc. | 1,611,338 | 0.00 USD |